Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $15.6300 (-2.31%) ($15.5700 - $16.7000) on Thu. Jun. 15, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.19% (three month average) | RSI | 46 | Latest Price | $15.6300(-2.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.8% a day on average for past five trading days. | Weekly Trend | EDIT advances 4.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(62%) IBB(62%) XBI(60%) IWO(57%) ARKK(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.095% in a week (0% probabilities). VIXM(-13%) TLT(-5%) SHY(-5%) UUP(-4%) GDXJ(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.095% (StdDev 4.19%) | Hourly BBV | 0 () | Intraday Trend | -1.3% | | | |
|
Resistance Level | $15.73 | 5 Day Moving Average | $15.89(-1.64%) | 10 Day Moving Average | $15.38(1.63%) | 20 Day Moving Average | $15.73(-0.64%) | To recent high | -37.3% | To recent low | 14.4% | Market Cap | $971m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |